Clinicians should monitor patients with stones, even if they are asymptomatic, to slow kidney function decline, investigators suggest. Even asymptomatic kidney stones may spur kidney function decline ...

The US Food and Drug Administration (FDA) on Thursday released new guidance providing a qualified context for use for the biomarker total kidney volume (TKV) in studies for the treatment of the common ...

Pregnancy does not appear to affect autosomal dominant polycystic kidney disease progression, according to study data ...

—Mayo Clinic researchers recently studied an algorithm based on artificial intelligence (AI) for measuring magnetic resonance-derived total kidney volume in autosomal dominant polycystic kidney ...

The combination of ADPKD genotype and baseline kidney size can predict rapid kidney function decline in routine clinical practice. Combining genotype and kidney length can identify nearly 9 out of 10 ...

Add Yahoo as a preferred source to see more of our stories on Google. Sep. 3—(StatePoint) This article is sponsored by Otsuka America Pharmaceutical, Inc. Each year, September 4 marks Polycystic ...

Researchers in Berlin have used base editing to repair mutations that cause the kidney disorder ADPKD in cells from both mice and humans. In mice, a team led by Michael Kaminski was able to ease a key ...

Jul 14, 2025, 6:41am EDT Updated: Jul 14, 2025, 7:26am EDT Courtesy of Renasant Renasant Bio CEO Emily Conley From the San Francisco Business Times. Patients with a life-threatening genetic kidney ...

Autosomal dominant polycystic kidney disease (ADPKD) affects about 1 in 1,000 to 4,000 people worldwide. While most patients can typically live a normal life, advanced stages of the disease may ...

In this study, the rate of ICA was more than twice as high among those with ADPKD compared with those with another primary nephrological diagnosis. Patient education—including knowledge about risk ...